Showing results (41-50 of 315) with videos related to
Sort By:
Pageof 32
Best Practice & Research. Clinical Gastroenterology|July 23, 2019
IL12/23 or selective IL23 inhibition for the management of moderate-to-severe Crohn's disease?Christopher Ma, Remo Panaccione, Reena Khanna, et al.Journal of the American Chemical Society|January 22, 2004
Single-crystal CdSe nanosawsChristopher Ma, Yong Ding, Daniel Moore, et al.The American Journal of Gastroenterology|January 14, 2021
Gender Disparities in Food Security, Dietary Intake, and Nutritional Health in the United StatesChristopher Ma, Stephanie K M Ho, Siddharth Singh, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 10, 2021
Effectiveness of Reinduction and/or Dose Escalation of Ustekinumab in Crohn's Disease: A Systematic Review and Meta-analysisJoseph Meserve, Christopher Ma, Parambir S Dulai, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 12, 2018
Concomitant Use of Aminosalicylates Is Not Associated With Improved Outcomes in Patients With Ulcerative Colitis Escalated to VedolizumabChristopher Ma, Paulo G Kotze, Abdulelah Almutairdi, et al.Current Opinion in Pharmacology|February 17, 2022
Eosinophilic esophagitis: New molecules, better life?Angela Y Lam, Christopher Ma, Jeffrey K Lee, et al.Alimentary Pharmacology & Therapeutics|March 1, 2022
Review article: therapeutic targets for the pharmacologic management of coeliac disease-the future beyond a gluten-free dietMichael Klonarakis, Christopher N Andrews, Maitreyi Raman, et al.Inflammatory Bowel Diseases|November 18, 2021
Epidemiology and Natural History of Perianal Crohn's Disease: A Systematic Review and Meta-Analysis of Population-Based CohortsLester Tsai, Jeffrey D McCurdy, Christopher Ma, et al.Drug Safety|March 5, 2019
Benefit-Risk Assessment of Vedolizumab in the Treatment of Crohn's Disease and Ulcerative ColitisRobert Battat, Christopher Ma, Vipul Jairath, et al.The American Journal of Gastroenterology|March 28, 2023
Comparative Speed of Early Symptomatic Remission With Advanced Therapies for Moderate-to-Severe Ulcerative Colitis: A Systematic Review and Network Meta-AnalysisDhruv Ahuja, Mohammad Hassan Murad, Christopher Ma, et al.Pageof 32